RMD
ResMed Inc.
Large cap$28.3B
↓ 33%$194.78
PEG 1.1ResMed's profitability, revenue, and debt held up through a 33% drop from its 52-week high.
52-wk range
$180.27$291.57
Fundamentals holding up through the dip.
4 of 4 fundamentals trending the right way over the past few years.
- RevenueGrowing
- '22
- 3.6B
- '23
- 4.2B
- '24
- 4.7B
- '25
- 5.1B
- vs last qtr
- ↑0.6%
- IncomeGrowing
- '22
- 779M
- '23
- 898M
- '24
- 1.0B
- '25
- 1.4B
- vs last qtr
- ↑1.6%
- DebtDecreasing
- '22
- 918M
- '23
- 1.6B
- '24
- 874M
- '25
- 852M
- vs last qtr
- ↓0.5%
- MarginsImproving
- '22
- 22%
- '23
- 21%
- '24
- 22%
- '25
- 27%
- vs last qtr
- ↑0.3%
| '22 | '23 | '24 | '25 | vs last quarter | ||
|---|---|---|---|---|---|---|
| Revenue | Growing | 3.6B | 4.2B | 4.7B | 5.1B | ↑0.6% |
| Income | Growing | 779M | 898M | 1.0B | 1.4B | ↑1.6% |
| Debt | Decreasing | 918M | 1.6B | 874M | 852M | ↓0.5% |
| Margins | Improving | 22% | 21% | 22% | 27% | ↑0.3% |
Price history
- 30-day change: 3.8%
- 90-day change: 15.3%
- Down 33.2% from 52-week high
Key metrics
25.2%
13%
27.4%
10.8%
18.8x
29.4x
16.0x
1.15
$28.3B
A snapshot frozen at the time the June 14, 2026 scan ran. Not investment advice.